Answers are grounded in this paper and cite their sources.
Direct-to-consumer personal genome testing is now widely available to consumers. Proponents argue that knowledge is power but critics worry about consumer safety and potential harms resulting from misinterpretation of test information. In this article, we consider the health system implications of direct-to-consumer personal genome testing, focusing on issues of accountability, both corporate and professional.
No takes yet. Share an insight, caveat, or question.
McGuire et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: